In conclusion, these findings raise the possibility that selectively decreasing skeletal muscle pyruvate uptake in obese and T2D patients may promote fat loss and restoration of whole-body insulin sensitivity. The gene discussed is INS; the disease is type 2 diabetes mellitus.